A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes

Moshe HodHelen Schneider Women’s Hospital, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University Tel AvivIsraelCorrespondence[email protected]

Elisabeth R. MathiesenCenter for Pregnant Women with DiabetesRigshospitalet;Department of Endocrinology;Faculty of Health Sciences, University of Copenhagen CopenhagenDenmark

Lois JovanovičSansum Diabetes Research Institute, Santa Barbara CAUSA

David R. McCanceMetabolic Unit, Royal Victoria Hospital BelfastUK

Marina IvanisevicDepartment of Obstetrics and Gynecology, University Hospital of Zagreb ZagrebCroatia

Santiago Durán-GarciaCatedra de Endocrinologia, Unidad de Diabetes y Embarazo, Hospital Universitario de Valme SevilleSpain

Lise BrøndstedNovo Nordisk A/S SøborgDenmark

Avideh NazeriNovo Nordisk A/S SøborgDenmark

Peter DammCenter for Pregnant Women with DiabetesRigshospitalet;Faculty of Health Sciences, University of Copenhagen CopenhagenDenmark;Department of Obstetrics, Rigshospitalet, University of Copenhagen CopenhagenDenmark

show all

A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes

Supplementary Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes

Supplementary Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date